Teva Respiratory Announces Positive Results From Phase III Trial of BDP HFA … – PR Newswire (press release)

Teva Respiratory Announces Positive Results From Phase III Trial of BDP HFA
PR Newswire (press release)
While AR itself is not life-threatening (unless accompanied by severe asthma or anaphylaxis), morbidity associated with the condition can be significant.

and more »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *